Search hospitals > California > Los Angeles
Cedars-Sinai Medical Center
Claim this profileLos Angeles, California 90048
Global Leader in Breast Cancer
Global Leader in Cancer
Conducts research for Pancreatic Cancer
Conducts research for Lung Cancer
Conducts research for Solid Tumors
1450 reported clinical trials
171 medical researchers
Summary
Cedars-Sinai Medical Center is a medical facility located in Los Angeles, California. This center is recognized for care of Breast Cancer, Cancer, Pancreatic Cancer, Lung Cancer, Solid Tumors and other specialties. Cedars-Sinai Medical Center is involved with conducting 1,450 clinical trials across 1,595 conditions. There are 171 research doctors associated with this hospital, such as Leo Mascarenhas, MD, Fataneh (Fae) Majlessipour, Saibal Kar, MD, and Raj Makkar.Area of expertise
1Breast Cancer
Global LeaderStage IV
HER2 negative
ER positive
2Cancer
Global LeaderStage IV
Stage III
Stage I
Top PIs
Leo Mascarenhas, MDChildren's Hospital Los Angeles4 years of reported clinical research
Expert in Cancer
Studies Soft Tissue Sarcoma
49 reported clinical trials
110 drugs studied
Fataneh (Fae) MajlessipourCedars Sinai Medical Center8 years of reported clinical research
Expert in Brain Tumor
Studies Cancer
29 reported clinical trials
74 drugs studied
Saibal Kar, MDLos Robles Regional Medical Center7 years of reported clinical research
Studies Mitral Regurgitation
Studies Mitral Valve Regurgitation
27 reported clinical trials
33 drugs studied
Raj MakkarCedars-Sinai Medical Center7 years of reported clinical research
Studies Valvular Heart Disease
Studies Mitral Regurgitation
24 reported clinical trials
37 drugs studied
Clinical Trials running at Cedars-Sinai Medical Center
Lung Cancer
Breast Cancer
Skin Cancer
Breast cancer
Crohn's Disease
Kidney Cancer
Non-Hodgkin's Lymphoma
Ovarian Cancer
Cancer
Testicular cancer
Durvalumab
for Lung Cancer
This phase III trial compares durvalumab to the usual approach (patient observation) after surgery for the treatment of patients with early-stage non-small cell lung cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. The usual approach for patients who are not in a study is to closely watch a patient's condition after surgery and to have regular visits with their doctor to watch for signs of the cancer coming back. Usually, patients do not receive further treatment unless the cancer returns. This study will help determine whether this different approach with durvalumab is better, the same, or worse than the usual approach of observation. Giving durvalumab may help patients live longer and prevent early-stage non-small cell lung cancer from coming back as compared to the usual approach.
Recruiting2 awards Phase 38 criteria
Ceralasertib + Durvalumab
for Non-Small Cell Lung Cancer
This phase III trial compares the effect of adding AZD6738 to durvalumab versus durvalumab alone to increase time without cancer in patients with non-small cell lung cancer, following treatment with chemotherapy and surgery. AZD6738 may stop the growth of tumor cells and may kill them by blocking some of the enzymes needed for cell growth. Durvalumab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. A monoclonal antibody is a type of protein that can bind to certain targets in the body, such as molecules that cause the body to make an immune response (antigens). Adding AZD6738 to durvalumab may increase time without cancer in patients with non-small cell lung cancer, following treatment with chemotherapy and surgery.
Recruiting2 awards Phase 310 criteria
Osimertinib + Carotuximab
for Lung Cancer
The purpose of this study is to examine the combination of osimertinib and carotuximab to assess the safety and find the recommended dose for treatment of advanced EGFR-mutated non-small cell lung cancer (NSCLC). Safety and tolerability will be measured by the number of dose-limiting toxicities, according to National Cancer Institute Common Toxicity Criteria for Adverse Events (NCI CTCAE) Version 5, to find the maximum tolerated dose. The secondary objectives include evaluating the rate of objective response rate, duration of response, progression-free survival, and disease control rate, along with assessing biomarkers through tumor tissue and circulating tumor DNA.
Recruiting2 awards Phase 115 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Cedars-Sinai Medical Center?
Cedars-Sinai Medical Center is a medical facility located in Los Angeles, California. This center is recognized for care of Breast Cancer, Cancer, Pancreatic Cancer, Lung Cancer, Solid Tumors and other specialties. Cedars-Sinai Medical Center is involved with conducting 1,450 clinical trials across 1,595 conditions. There are 171 research doctors associated with this hospital, such as Leo Mascarenhas, MD, Fataneh (Fae) Majlessipour, Saibal Kar, MD, and Raj Makkar.
Where is Cedars-Sinai Medical Center located?
**Cedars-Sinai Medical Center**
- **Address:** 8700 Beverly Blvd, Los Angeles, CA 90048
- **Directions:** Take the I-10 E or I-10 W to exit 7B for La Cienega Blvd. Head north on La Cienega Blvd and turn right onto Beverly Blvd.
Who should I call to ask about financial aid or insurance network?
**Cedars-Sinai Medical Center Contact Information:**
- **Patient Financial Services:**
- General Inquiries: (323) 866-8600
- Billing and Insurance Inquiries: 866-803-1777 (Monday through Friday, 8 am - 4:30 pm PT)
- **Patient Financial Advocates:**
- For Admitted Patients: 310-423-5071
For financial assistance, please visit our website at [cedars-sinai.org/billing-insurance/help-paying-your-bill.html](cedars-sinai.org/billing-insurance/help-paying-your-bill.html) to access the necessary resources.
What insurance does Cedars-Sinai Medical Center accept?
Cedars-Sinai Medical Center accepts more than 100 insurance plans, including private insurance, HMOs, and PPOs. They have contracts with Blue Cross PPO, Vivity HMO, and Blue Cross HMO, which may necessitate PCP selection and referrals for specific services. Additionally, they provide resources for individuals looking to purchase health insurance independently, with Blue Shield PPO covering their medical center and physicians.
What awards or recognition has Cedars-Sinai Medical Center received?
Cedars-Sinai Medical Center, located in Los Angeles, California, is celebrated for its exceptional medical care, having won the NRC Health's Consumer Choice Award for 20 consecutive years. It stands as a premier center for biomedical research, ranking among the top non-university hospitals in the US for competitive research funding from the National Institutes of Health.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.